Xtant Medical Holdings, Inc.
XTNTAMEXHealthcare● Active
$0.45
$-0.01(-1.62%)
Market Cap$62907938
P/E Ratio—
52W High$0.95
52W Low$0.44
Xtant Medical Holdings, Inc. (XTNT) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · XTNT · as of 2026-06-09
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $0.13B | $0.12B | $0.09B | $0.06B | $0.06B |
| Cost of Revenue | $0.05B | $0.05B | $0.04B | $0.03B | $0.02B |
| Gross Profit | $0.08B | $0.07B | $0.06B | $0.03B | $0.03B |
| Gross Margin %(computed) | 62.92% | 58.17% | 60.75% | 55.44% | 58.79% |
| Operating Expenses | |||||
| R&D Expenses | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| G&A Expenses | $0.03B | $0.03B | $0.03B | $0.02B | $0.01B |
| Total Operating Expenses | $0.08B | $0.08B | $0.07B | $0.04B | $0.04B |
| Operating Income | $0.01B | ($0.01B) | ($0.01B) | ($0.01B) | ($0.00B) |
| Operating Margin %(computed) | 5.44% | -10.30% | -11.13% | -11.65% | -6.97% |
| Interest Income | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Interest Expense | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Income Before Tax | $0.01B | ($0.02B) | ($0.00B) | ($0.01B) | ($0.00B) |
| Income Tax Expense | $0.00B | $0.00B | ($0.00B) | $0.00B | $0.00B |
| Net Income | $0.00B | ($0.02B) | $0.00B | ($0.01B) | ($0.00B) |
| Net Margin %(computed) | 3.71% | -14.03% | 0.72% | -14.64% | -8.77% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $0.04 | $-0.12 | $0.01 | $-0.09 | $-0.06 |
| Wtd Avg Shares | 0.14B | 0.13B | 0.12B | 0.09B | 0.09B |
| EBITDA | $0.02B | ($0.01B) | $0.01B | ($0.01B) | ($0.00B) |
| EBITDA Margin %(computed) | 11.87% | -6.72% | 5.56% | -9.36% | -4.55% |
Data source: Financial Modeling Prep · Last updated: 2026-06-09 · USD · B
Explore more Xtant Medical Holdings, Inc. data
About Xtant Medical Holdings, Inc. (XTNT) Income Statement
Xtant Medical Holdings, Inc. (XTNT) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2025, XTNT reported revenue of $0.13B, gross profit of $0.08B (gross margin 62.92%), and net income of $0.00B — a net profit margin of 3.71%.
Frequently asked questions
XTNT · 4 questionsXtant Medical Holdings, Inc. (XTNT) reported revenue of $0.13B for 2025, up 14.2% year-over-year.
XTNT revenueXTNT salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09